Pacira BioSciences, Inc. News Releases http://investor.pacira.com/ Pacira BioSciences, Inc. News Releases en Pacira BioSciences Appoints Former Johnson & Johnson Executive, Max Reinhardt, as President http://investor.pacira.com/news-releases/news-release-details/pacira-biosciences-appoints-former-johnson-johnson-executive-max Reinhardt brings extensive global experience leading multi-billion-dollar businesses to Pacira PARSIPPANY, N.J. , June 19, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the appointment of Max Reinhardt as the company’s president. Mr. Wed, 19 Jun 2019 07:30:00 -0400 Pacira BioSciences, Inc. News Releases 13106 New Analysis Shows Use of EXPAREL Associated with Improved Clinical and Economic Outcomes Following Hip Replacement Surgery http://investor.pacira.com/news-releases/news-release-details/new-analysis-shows-use-exparel-associated-improved-clinical-and Results from 10 U.S. hospitals with highest EXPAREL use in total hip arthroplasties PARSIPPANY, N.J. , June 12, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced new data on the use of EXPAREL® (bupivacaine liposome injectable suspension) following total hip Wed, 12 Jun 2019 07:30:00 -0400 Pacira BioSciences, Inc. News Releases 13091 Pacira Announces Publication of Pivotal Study of EXPAREL as a Single-Dose Interscalene Brachial Plexus Nerve Block in Patients Undergoing Shoulder Surgery http://investor.pacira.com/news-releases/news-release-details/pacira-announces-publication-pivotal-study-exparel-single-dose Results, which included significant reductions in pain and opioids, published in Pain Medicine PARSIPPANY, N.J. , June 04, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced the publication of its multinational Phase 3 study supporting the efficacy and safety of Tue, 04 Jun 2019 07:30:00 -0400 Pacira BioSciences, Inc. News Releases 12996 Pacira BioSciences to Present at the Jefferies 2019 Healthcare Conference http://investor.pacira.com/news-releases/news-release-details/pacira-biosciences-present-jefferies-2019-healthcare-conference PARSIPPANY, N.J. , May 28, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will participate in an analyst-led fireside chat at the Jefferies 2019 Healthcare Conference at 10:00 AM ET on Tuesday, June 4, 2019 . Live audio of the event can be accessed by Tue, 28 May 2019 07:30:00 -0400 Pacira BioSciences, Inc. News Releases 12986 Pacira BioSciences to Present at Two Healthcare Conferences in May http://investor.pacira.com/news-releases/news-release-details/pacira-biosciences-present-two-healthcare-conferences-may PARSIPPANY, N.J. , May 07, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the following two healthcare conferences: Bank of America Merrill Lynch 2019 Healthcare Conference in Las Vegas , on Tuesday, May 14 at 3:00 PM PT ( 6:00 PM ET ) 2019 Tue, 07 May 2019 07:59:31 -0400 Pacira BioSciences, Inc. News Releases 12966 Phase 4 Study Demonstrates Superiority of EXPAREL plus Bupivacaine versus Bupivacaine Alone in Cesarean Section Procedures http://investor.pacira.com/news-releases/news-release-details/phase-4-study-demonstrates-superiority-exparel-plus-bupivacaine – TAP block with EXPAREL provides significant reductions in opioids and pain scores – – Results presented at Society of Obstetric Anesthesia and Perinatology annual meeting – PARSIPPANY, N.J. , May 07, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. Tue, 07 May 2019 07:29:30 -0400 Pacira BioSciences, Inc. News Releases 12961 Pacira BioSciences Reports First Quarter 2019 Revenues of $91.3 Million http://investor.pacira.com/news-releases/news-release-details/pacira-biosciences-reports-first-quarter-2019-revenues-913 -- EXPAREL® net product sales of $90.6 million up 22.4 percent over prior year first quarter -- -- MyoScience acquisition advances leadership in non-opioid pain management; corporate name change to Pacira BioSciences reflects expanding product portfolio -- -- Conference call today at 8:30 a.m. Thu, 02 May 2019 08:00:46 -0400 Pacira BioSciences, Inc. News Releases 12956 Pacira to Report First Quarter 2019 Financial Results on Thursday May 2, 2019 http://investor.pacira.com/news-releases/news-release-details/pacira-report-first-quarter-2019-financial-results-thursday-may PARSIPPANY, N.J. , April 25, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on Thursday, May 2, 2019 . Following the release, the company will host a live conference call and Thu, 25 Apr 2019 07:30:14 -0400 Pacira BioSciences, Inc. News Releases 12951 Pacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraº System http://investor.pacira.com/news-releases/news-release-details/pacira-completes-acquisition-myoscience-advancing-leadership-non -- Adds highly complementary cryoanalgesia treatment to commercial offering -- -- New corporate name of Pacira BioSciences reflects expanding product portfolio -- PARSIPPANY, N.J. , April 09, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (“ Pacira”) (NASDAQ: PCRX) today announced that it has Tue, 09 Apr 2019 16:01:00 -0400 Pacira BioSciences, Inc. News Releases 12901 Pacira Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference http://investor.pacira.com/news-releases/news-release-details/pacira-pharmaceuticals-present-18th-annual-needham-healthcare PARSIPPANY, N.J. , April 02, 2019 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today reported that it will present at the 18 th Annual Needham Healthcare Conference at 3:30 PM ET on Tuesday, April 9, 2019 . Live audio of the presentation can be accessed by visiting the “Events” Tue, 02 Apr 2019 07:30:16 -0400 Pacira BioSciences, Inc. News Releases 12896